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ABSTRACT
Foot-and-mouth disease (FMD) is one of the most important livestock diseases in East Africa 
with outbreaks reported annually that cause severe economic losses. It is possible to control 
disease using vaccination, but antigenic matching of the vaccine to circulating strains is 
critical. To determine the relationship between foot-and-mouth disease viruses circulating 
in districts along the Uganda and Tanzanian border between 2016 and 2017 and currently 
used vaccines, phylogenetic analysis of the full VP1 virus sequences was carried out on 
samples collected from both sides of the border. A total of 43 clinical samples were collected 
from animals exhibiting signs of FMD and VP1 sequences generated from 11 of them. Eight 
out of the 11 sequences obtained belonged to serotype O and three belonged to serotype 
A. The serotype O sequences obtained showed limited nucleotide divergence (average of 
4.9%) and belonged to topotype East Africa-2, whereas the most common O-type vaccine 
strain used in the region (O/KEN/77/78) belonged to East Africa-1. The serotype A viruses 
belonged to topotype Africa-G1 (average nucleotide divergence 7.4%), as did vaccine strain 
K5/1980. However, vaccine strain K35/1980 belonged to Africa G VII with an average sequence 
divergence of 20.5% from the study sequences. The genetic distances between current 
vaccine strains and circulating field strains underscores the crucial need for regular vaccine 
matching and the importance of collaborative efforts for better control of FMD along this 
border area.
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INTRODUCTION
Foot-and-mouth disease (FMD) is an important livestock disease that can affect all 
cloven-hooved animals. The disease is ranked among 117 notifiable diseases by the World 
Organisation for Animal Health and requires immediate action for controlling its spread. 
Although the disease causes low mortality in adult animals, the economic effects from an 
outbreak include loss of income and food availability, and increased expenditure at both the 
individual and national level [1,2].
The foot-and-mouth disease virus (FMDV) is the aetiological agent of FMD with a genome 
length of approximately 8400 nucleotides. The non-enveloped positive sense RNA virus spreads 
through both direct contact and airborne transmission [3]. The virus belongs to the Picornaviridae 
family and Aphthovirus genus with seven serotypes existing globally (O, A, C, Asia 1, and Southern 
African Territories [SAT] 1, 2, and 3). The non-structural proteins of FMDV are involved mainly in 
virus replication and coded for by the regions 2A, 2B, 2C, 3A, 3B, 3Cpro and 3Dpol [4] while the 
structural proteins (SP) VP1, VP2, VP3 and VP4 are coded for by the regions, ID, IB, IC, and IA, 
respectively. The ID region that encodes VP1 is considered to be the most antigenically variable 
region of the FMDV and widely used to determine epidemiology and evolutionary relationships 
between FMDV strains and serotypes [5]. FMD viruses have therefore been grouped into 
epidemiological and genetic clusters called topotypes based on VP1 region sequences [4-6].
Out of 11 topotypes for serotype O viruses, four have been documented to circulate in 
Uganda, Kenya and Tanzania. These include; East Africa-1 (EA-1), EA-2, EA-3 and EA-4. 
Topotype EA-1 has primarily circulated in Uganda and Kenya between 1964 and 1996, but 
recent studies have revealed that it is currently restricted to Kenya whereas EA-2 is the most 
recently dominant topotype in the region. Topotype EA-3 and EA-3 are mostly restricted to 
Ethiopia and Kenya [7]. Serotype A viruses have been grouped into three major topotypes 
with over 26 genotypes of the virus. In East Africa, four recognized groupings (Africa-G-I, 
Africa G-II, Africa G-IV and Africa-VII) have been in circulation [8].
All seven serotypes, except for Asia 1, have been reported in East Africa [1,9-17], making it 
the region with the highest diversity of FMDV serotypes in the world. This high diversity has 
implications for FMD control through vaccination, with a need for frequent and rigorous 
comparisons between vaccines and circulating strains as well as the development of additional 
multivalent vaccines. Regular surveillance and characterisation of circulating serotypes is critical 
for selection of appropriate vaccine strains and to ensure the effectiveness of investments in FMD 
control. FMD vaccines are commonly used in Uganda with the country's annual expenditure on 
vaccination control ranging from US $58,000 to $1,088,820 [18]. The eastern Africa border areas 
have previously been implicated as risk areas for FMD circulation [19], making them important 
regions for FMD surveillance and control. The aim of this study was to determine the within- and 
between-topotype genetic diversity of FMD viruses isolated from cattle in the districts along the 
Uganda-Tanzania border and compare them with current vaccines in use.
MATERIALS AND METHODS
Sample collection and study areas
The sampling was approved by the Ministry of Agriculture Animal Industry and Fisheries 
(Letter No: LHE 138/1) and by the Tanzania Commission for Science and Technology 
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(Permit No: 2016-277-NA-2016-214), and farmers all provided consent before sampling 
was performed. During 2016-2017, a total of 43 clinical samples were collected from cattle 
on farms that reported FMD outbreaks in the districts of Isingiro and Rakai located in the 
western part of Uganda, and the Missenyi and Kyerwa districts located in the north-western 
part of Tanzania (Fig. 1). Samples were stored in duplicate, one in phosphate buffered saline 
(PBS) in liquid nitrogen, the other in RNAlater (Ambion, USA). Samples collected included 
probang tissue, mouth and foot lesion swabs, epithelial tissue, blood, and saliva from 
animals that exhibited clinical signs of the disease.
RNA extraction and one-step real time reverse transcriptase-polymerase 
chain reaction (rRT-PCR)
Extraction of total viral RNA was performed using Invitrogen PureLink RNA Mini Kits (USA). 
The samples were diagnosed by rRT-PCR using Invitrogen SuperScript III One-Step RT-PCR 
System with Platinum Taq DNA Polymerase (USA) and a Stratagene Mx3000P thermocycler 
(2009, USA). The 25 µL reaction mix consisted of 2 µL of each primer with a concentration 
of 10 pmol, 1.5 µL of the probe, 1.5 µL of nuclease free water, 12.5 µL of buffer, 0.5 µL of 
Supercript III RT/Platinum Taq mix and 5 µL of template. The cDNA synthesis and PCR 
were run under the following conditions: 50oC for 30 min, 95oC for 2 min, followed by 40 
amplification cycles of 95oC for 15 sec, 56oC for 30 sec, 72oC for 30 sec and final extension 
at 72oC for 3 min. The sequences of the primers and probe set targeted the 3D open reading 
frame (ORF) of the FMDV genome and as described by [20] (Table 1).
Antigen enzyme linked immune sorbent assay (Ag ELISA)
The 35 samples that were positive by rRT-PCR were processed and subjected to antigen ELISA 
that was performed using the IZSLER Antigen ELISA kit obtained from the Pirbright Institute, 
Pirbright, UK. Small pieces of epithelial and probang tissues were cut using sterile forceps 
and scissors and placed in separate sterile mortars, 10 mL of PBS was added, the tissues 
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Fig. 1. Study districts. Map showing border districts of Isingiro and Rakai in Uganda along with Missenyi and 
Kyerwa in Tanzania.
Table 1. Primer and probe sequences used for real time reverse transcriptase-polymerase chain reaction
Primers/probe Sequence Gene
Forward primer 5′-ACT GGG TTT TAC AAA CCT GTG A-3′ 3D
Reverse primer 5′-TCC TTT GCA CGC CGT GGG AC-3′ 3D
Probe (FAM-TAMRA) 5′-GCG AGT CCT GCC ACG GA-3′ 3D
were crushed using sterile pestles and another 5 mL of PBS was added. The suspension was 
centrifuged at 2,000 g for 10 min, and the supernatants were subjected to the assay procedure 
following the manufacturer's instructions. The test included a positive control with optical 
density (OD) > 0.1 and a negative control with OD < 0.1. All samples with OD ≥ 0.1 were 
considered positive for FMDV while those with OD < 0.1 were considered negative.
Amplification of the VP1 coding region using conventional PCR
The samples that were positive by rRT-PCR were subjected to conventional PCR using 
Invitrogen SuperScript III One-Step PCR System with Platinum Taq DNA Polymerase. 
Serotype-specific primers targeting VP1 were selected based on the antigen ELISA results 
(results not shown). The primers were as described by [20] and are presented in Table 2. For 
each sample, the reaction master mix was prepared by adding 9.2 µL of nuclease-free water, 
1.6 µL of each primer (reverse and forward), 0.8 µL of dNTPs, 4 µL of buffer, 0.8 µL of Qiagen 
One–step RT-PCR enzyme and 2.0 µL of template, leading to a final 20 µL volume. The 
four serotype-specific PCRs included nuclease-free water as a negative control and known 
positive controls that were supplied by the National Animal Disease Diagnostic Centre as 
RNA extracts that had previously been stored at −80oC. The PCR was run in a Techne TC-412 
thermocycler (Techne, USA) using the following cycle conditions; 50oC for 30 min and 95oC 
for 15 min, 95oC for 10 sec, followed by 35 cycles of 30 sec at 60oC for serotype O, 30 sec at 
55°C for serotype A and 30 sec at 50°C for SAT 1, SAT 2 and SAT 3 with extensions of 72oC for 
30 sec and 72oC for 10 min as modified from a protocol described by Knowles et al. [20].
Gel electrophoresis and cleaning of PCR products
The PCR products were analysed on a 2% agarose Tris/borate/EDTA gel stained with 1% 
ethidium bromide including a 1 kb Gene ruler DNA ladder (Fermentas, USA). Removal of excess 
primers and nucleotides was undertaken using the PureLink PCR Purification kit according to 
the manufacturer's instruction. Elution was achieved with 50 µL of elution buffer.
Sequencing of PCR products
The PCR amplicons were sent to Macrogen (Korea) for sequencing using the BigDye 
Terminator v3.1 Cycle Sequencing Kit (Life Technologies, USA). Universal reverse primer 
NK72 was employed for all samples whereas specific primers (Table 2) were used for each of 
the different serotypes as described by Knowles et al. [20].
Sequence analysis
The nucleotide sequences obtained were edited using CLC Work Bench version 9.5.3 
(Qiagen, USA). The generated sequences were run through the Basic Local Alignment 
Search Tool (BLAST) [21] in order to retrieve related sequences from Genbank. The serotype 
O VP1 sequences were aligned using ClustalW as implemented in Molecular Evolutionary 
Genomic Analysis (MEGA) version 7 [22] and trimmed down to 639 nucleotides. Serotype 
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Table 2. Serotype primers were used to perform conventional reverse transcriptase-polymerase chain reaction
Serotype Name Sequence Direction Gene Size
O O–1C244F GCAGCAAAACACATGTCAAACACCTT + VP3 1,165
O/A/C/Asia EUR–2B52R GACATGTCCTCCTGCATCTGGTTGAT − 2B
A A–1C562F TACCAAATTACACACGGGAA + VP3 866
SAT 1 SAT1–1C559F GTGTATCAGATCACAGACACACA + VP3 1,043
SAT 1–3 SAT–2B208R ACAGCGGCCATGCACGACAG − 2B
SAT2 SAT2 P1–1223F TGAACTACCACTTCATGTACACAG + VP3 1,279
SAT3 SAT3–P1–1222F AATCTGCATTTCATGTACAC + VP3 1,277
SAT, Southern African Territories.
A VP1 sequences obtained were trimmed to 640 nucleotides after alignment with other 
selected serotype A sequences from Genbank. Phylogenetic analysis was performed with 
the neighbour-joining tree method in MEGA 7 based on the Kimura 2-model parameter 
for nucleotide substitution [23]. The robustness of the phylogeny was assessed with 1,000 
bootstrap replicates. Sequences from this study were compared with selected virus sequences 
derived from cattle from Uganda, Tanzania, Malawi, Zambia, Burundi and Kenya (Table 3). 
Sequences from Hong Kong, Vietnam and Turkey were employed as out-groups.
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Table 3. List of the foot-and-mouth disease virus serotype O and A VP1 sequences employed in the study
SN Country Year Serotype Accession Number Sequence Name Reference
1 Tanzania 2016 O Not yet available TAN/02/O/2016 This study
2 Tanzania 2016 O Not yet available TAN/07/O/2016 This study
3 Tanzania 2017 O Not yet available TAN/04/O/2017 This study
4 Tanzania 2017 O Not yet available TAN/08/O/2017 This study
5 Uganda 2017 O Not yet available UG/13/O/2017 This study
6 Uganda 2017 O Not yet available UG/03/O/2017 This study
7 Uganda 2017 O Not yet available UG/09/O/2017 This study
8 Uganda 2017 O Not yet available UG/11/O/2017 This study
9 Uganda 2005 O HM756628 U25/06 [9]
10 Tanzania 2008 O KF561684 TAN/16/2008 [12]
11 Uganda 2004 O HM756621 U20B/04 [9]
12 Tanzania 2002 O MF592671 O/TAN/10/2014 [1]
13 Zambia 2006 O KU821591 O/ZAM/14/2010 [25]
14 Uganda 2009 O JN974308 OUGA2009LIRA [10]
15 Uganda 2011 O KF478938 U04/11 [13]
16 Tanzania 2009 O KF561685 TAN/5/2009 [12]
17 Tanzania 2013 O MF592650 O/TAN/10/2013 [1]
18 Tanzania 2012 O MF592623 O/TAN/38/2012 [1]
19 Malawi 1998 O DQ165074 O/MAL/1/98 Unpublished
20 Ethiopia 2007 O FJ798138 ETH/26/2007 [28]
21 Tanzania 1998 O KF561677 TAN/9/98 [12]
22 Tanzania 2004 O KF561682 TAN/14/2004 [12]
23 Uganda 1996 O EU919247 O/UGA/5/96 [29]
24 Kenya 1978 O HM756588 O/KEN/77/78 [9]
25 Kenya 1995 O HM756601 K56/95 [9]
26 Kenya 2009 O KR149720 KEN/62/2009 [16]
27 Kenya 2011 O KF135292 K91/11 [16]
28 Hong Kong 2002 O AY317098 HKN/2002 [30]
29 Tanzania 2017 A Not yet available TAN/10/A/2017 This study
30 Tanzania 2017 A Not yet available TAN/12/A/2017 This study
31 Uganda 2017 A Not yet available UGA/5/A/2017 This study
32 Uganda 2013 A KP089985 U75/13 [13]
33 Kenya 2009 A KF561703 KEN/22/2009 [12]
34 Tanzania 2009 A KF561697 TAN/47/2009 [12]
35 Kenya 2008 A KF561702 KEN/28/2008 [12]
36 Tanzania 2009 A KF561693 TAN/9/2009 [12]
37 Tanzania 2008 A KF561690 TAN/11/2008 [12]
38 Kenya 2008 A KF561701 KEN/8/2008 [12]
39 Kenya 1966 A KF561699 KEN/42/66 [12]
40 Tanzania 1968 A KF561688 TAN/3/68 [12]
41 Tanzania 1980 A KF561689 TAN/4/80 [12]
42 Kenya 1980 A KJ440846 K35/1980 [17]
43 Kenya 1980 A KJ440848 K5/1980 [17]
44 Uganda 1966 A KF112925 A/UGA/13/66 [31]
45 Ghana 1973 A KF561698 GHA/16/73 [12]
46 Nigeria 1973 A KF561704 NGR/2/73 [12]
47 Turkey 2005 A FJ755100 A/TUR/12/2005 [32]
48 Vietnam 2010 A JQ070332 VIT/1/2010 [33]
RESULTS
The FMDV genome was successfully amplified in 35/43 samples using rRT-PCR with cycle 
threshold (CT) values of less than 35. VP1 sequences were only recovered from 11 of these 
samples by serotype-specific conventional PCR. The obtained band sizes were as expected; 1,065 
base pairs (bp) for serotype O and 866 bp for serotype A. BLAST analysis of 11 VP1 sequences, 
two from 2016 and nine from 2017, showed that eight were serotype O and three were serotype 
A. Four serotype O sequences were from the Isingiro district (Uganda) and four from Tanzania 
(one from Kyerwa and three from the Missenyi districts). For the serotype A sequences, one 
was from the Rakai district and two from Missenyi, all collected in 2017. Additionally, one of 
the epidemiological units (farms) in Tanzania had both O and A FMD viruses (TAN/08/O/2017 
and TAN/10/A/2017) detected during a single outbreak that occurred in July 2017. Antigen ELISA 
results showed that epithelial samples were positive for serotypes O, A, and SAT 2.
Analysis of the serotype O VP1 nucleotide sequences
The eight Ugandan and Tanzanian serotype O VP1 sequences obtained from this study had 
an average nucleotide divergence of 4.9% and grouped together into one clade as shown 
in the neighbour-joining tree (Fig. 2). The four sequences from Isingiro, Uganda had 
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Fig. 2. The serotype O neighbour-joining tree. The probability of trees in which the associated taxa clustered 
together is shown next to the branches. *Study strains; †Vaccine strains.
100% nucleotide similarity and so only one sequence was used to represent them all in the 
neighbour-joining tree. The O-type sequences were closest to sequences from Tanzania 
obtained in 2014 (O/TAN/10/2014) and from Zambia in 2010 (O/ZAM14/2010) with an average 
intra-serotype nucleotide divergence of 7%. The O-type sequences that were generated in this 
study belonged to topotype East Africa-2 (EA-2). The study sequences grouped differently 
from the vaccine strain, O/KEN/77/78, which belonged to topotype EA-1.
Analysis of the serotype O VP1 amino acid sequences
Twenty 200-amino-acid-long sequences were aligned and compared to the vaccine strain, 
O/KEN/77/78, currently used in East Africa. The Arginine (R) Glycine (G) Aspartate (D) 
(RGD) motif at positions 139–142 was maintained, while the flanking region upstream of 
the RGD (positions 129–137) showed high variability between the vaccine strain and field 
strains from this study (Fig. 3). At the upstream −10 RGD motif, there were up to seven amino 
acid changes. Study viruses exhibited little variation −10 downstream of the RGD motif, 
whereas there was considerable variation +10 up stream of the motif. Viruses TAN/07/O/2016, 
TAN/02/O/2016 and UG/13/O/2017 were more closely aligned in their amino acid sequences 
compared to the others. Non-synonymous mutations occurred at position 131 in 
TAN/08/O/2017 where G was changed to V and position 135 in sequences TAN/04/O/2017 and 
TAN/08/O/2017, where A was changed to V. Other non-synonymous changes were observed in 
sequences TAN/04/O/2017 and TAN/08/O/2017, where P was changed to A and V was changed 
to A, respectively. Non synonymous changes were also seen in positions 129 (R to L), 131 (G 
to S), 132 (R to G), 133 (A to T), 134 (P to S), 138 (V to T) and 136 (T to A). While amino acid 
alignments between UG/13/O/2017 from Uganda and Tanzanian strain TAN/02//2016 were a 
close match, the average amino acid difference between sequences obtained from this study 
and the serotype O vaccine strain O/KEN/77/78 was 22.04%.
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Fig. 3. The serotype A neighbour-joining tree showing 20 nucleotide sequences. The probability of trees in which the 
associated taxa clustered together is shown next to the branches. *Study sequences; †The vaccine strain in use.
Analysis of the serotype A VP1 nucleotide sequences
The three serotype A viruses from this study grouped together with the Ugandan sequence that 
was obtained in 2013 from the Isingiro district [13] (Fig. 4). These viruses belonged to topotype 
Africa G-I and had an overall 7.4% sequence divergence between each other. The vaccine strain, 
K5/1980, belonged to the same Africa G-I topotype, but was 16.4% different from the study 
strains, whereas the vaccine strain, K35/1980, belonged to topotype, Africa G-VII.
Analysis of the serotype A VP1 amino acid sequences
The vaccine strain, K5/1980, which belonged to the same topotype as the study strains (Africa 
G-I) was used as reference strain for amino acid alignment alongside selected sequences. 
The results showed that there were 50 variable positions out of the 196 positions, and that the 
study strains were different from the reference strain at the 124–130 positions (Fig. 5). The 
RGD motif (144–146) for receptor-binding proteins was conserved across all viruses included 
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Fig. 4. Amino acid sequence alignment for serotype O sequences inferred from the study nucleotide sequences (*) with the reference vaccine strain O/O/
KEN/77/78 (†) currently incorporated in the vaccines used in Uganda. The conserved RGD motif is within the purple rectangle. The dots represent identical 
regions to the reference strain, O/O/KEN/77/78, while the green and blue rectangles indicate the changes upstream and downstream of the RGD region.
in the alignment. However, flanking regions upstream of the RGD motif (from −1 to −6) were 
highly variable, with major changes from 138–143. Two amino acid changes were observed 
downstream +2 from the RGD motif. Non-synonymous mutations occurred at position 138 
(K to T) and position 140 (A to T). Other non-synonymous changes were observed at position 
141 (G to T and G to R). The average amino acid difference between sequences obtained from 
this study and the serotype A vaccine strain K5/80 was 15.9%.
DISCUSSION
The main aim of this work was to compare FMDV isolates from Uganda and Tanzania 
following outbreaks that occurred in the districts situated along the border of Uganda and 
Tanzania between 2016 and 2017. The study also sought to compare the variability between 
the vaccine strains and viruses obtained. The presence of two major outbreaks in this area 
and circulation of two FMDV serotypes, A and O, within a span of roughly 8 months in this 
border area highlights the high frequency of outbreaks. The reappearance of serotype A and 
high similarity between virus strains circulating between the two countries suggests the 
border is readily permeable to livestock movements and spread of FMD viruses. The presence 
of two serotypes on the same farm at the same time demonstrates the need for more 
appropriate multivalent vaccines given vaccines have to be antigenically similar to circulating 
viral strains [24].
Although analysis of whole genomes is now widely used in epidemiological and evolutionary 
studies, allowing for high-resolution comparison of viruses, sequencing and analysis of the 
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Fig. 5. Alignment of serotype A partial VP1 amino acid sequences inferred from the study nucleotide sequences (*) with the K5/1980 vaccine sequence (†) and 
selected serotype A sequences. The conserved RGD motif is within the blue rectangle. The dots represent identical regions to the reference strain, K5/1980. The 
orange rectangle shows a portion of the upstream region of the RGD motif.
sub-genomic VP1 region of the FMDV provides a fast, accessible and affordable method that 
can generate valuable evolutionary and epidemiological insights. Therefore, the strains of 
FMDV are organised into major groups called topotypes based on phylogenetic analysis of the 
VP1 region [5,6].
The eight serotype O viruses obtained in this study belonged to the same topotype, EA-
2, consistent with other recent studies on FMD in Uganda and Tanzania, which have 
shown FMD viruses clustering within the EA-2 topotype [5,13,15,25]. Conversely, in the 
neighbouring country, Kenya, recent serotype O viruses that were responsible for outbreaks 
between 2010 and 2011 belonged to two topotypes, EA-2 and EA-4 [17].
All serotype O sequences from this study belonged to same topotype, EA-2, with an overall 
nucleotide sequence divergence of 4.9%. This low intra-serotype difference between 
Ugandan and Tanzanian sequences suggests that the viruses were responsible for outbreaks 
in this study had a similar origin. This reinforces results of previous work [9,10,12,13] that 
demonstrated a close relationship between FMD viruses responsible for outbreaks in Uganda 
and Tanzania. This study provides new insights into the relationships between trans-border 
outbreaks and emphasizes border areas as important for FMD epidemiology. The four 
districts that were included in this study each share the Tanzanian-Ugandan border. With 
this, the work presented here further supports the view that back and forth human-livestock 
movement is playing a significant role in trans-boundary disease spread [19,26]. This study 
additionally provides new insights into relationships between trans-boundery outbreak 
viruses and vaccine strains. The serotype O vaccine strain (O/KEN/77/78) that is incorporated 
in the trivalent vaccine currently utilised in East Africa belongs to a different topotype, EA-1, 
from the serotype O virus isolated from outbreaks and is divergent at over 20% of amino acid 
positions. A recent vaccine-matching study also demonstrated that the O/KEN/77/78 vaccine 
strain had a low in vitro match to recent circulating strains in East Africa belonging to EA-2 
and EA-3 [7]. Furthermore, alignment of the deduced amino acid sequences shows a number 
of differences between the reference vaccine strain and circulating strains, confirming that 
the currently used vaccine may not provide protection against current serotype O FMDVs. 
Non-synonymous changes observed in the study sequences downstream and upstream of the 
RGD motif are likely to be antigenically significant and have been reported to be significantly 
involved in determining receptor specificity for FMDV [27].
Prior to this study, serotype A viruses were most recently isolated from Uganda in 2013 from 
the Wakiso district and before then in 2002 [18]. The low frequency of detection of serotype 
A in Tanzania has also been highlighted and was attributed to either poor surveillance 
systems or certain epidemiological factors associated with the serotype [12]. This study [13] 
further implicates cross-border movement as a possible factor in the reappearance of type A 
viruses as it may not be endemic to Tanzania. A recent study by Casey-Bryars [1] in Tanzania 
showed that serotype outbreaks appeared in waves and a particular serotype may take a while 
to reappear after an outbreak. This could also be the case for serotype A viruses in Uganda. 
Serotype A sequences obtained in this study were closely related to viral sequences obtained 
from the 2013 outbreak from the Wakiso district in Uganda. Namatovu et al. [13] suggested 
that the origin of the serotype A virus isolated in 2013 could have been from another country 
given that it was genetically different from previously isolated serotype A viruses from 
Uganda. However, the similarity between the 2013 and 2016/2017 viruses detected in our 
study suggests that the serotype A virus may now be circulating as an endemic infection in 
Uganda with frequent cross-border transmission between Tanzania and Uganda. Although 
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the vaccine strain K5/1980 belongs to the same topotype as the circulating serotype A strains, 
it is important to note that there were a number of non-synonymous differences in amino 
acid alignment. Thus, vaccine performance studies must also be carried out. However, the 
vaccine strain, K35/1980, belongs to a different topotype, Africa G-V11, casting doubt on the 
effectiveness of this vaccine against A-type viruses presently circulating.
The results from this study show that the isolated serotype O viruses were all closely related 
and belonged to the EA-2 topotype, which is different from the topotype EA-1 vaccine strain 
that is currently being used in Uganda and Tanzania. The presence of serotype A both in 
Uganda and Tanzania is clearly shown in this study and the isolated serotype A viruses were 
demonstrated to belong to topotype Africa-GI, to which the vaccine strain, K5/1980, also 
belongs, whereas the vaccine strain, K35/1980, belongs to a different topotype, Africa-GVII.
There is a need for active routine surveillance systems and collaboration efforts between 
Tanzania and Uganda so that both governments have up-to-date information on currently 
circulating viruses to enable effective decision-making on vaccine strains to be deployed 
during vaccination campaigns. Moreover, vaccine-matching studies are paramount for 
determining how effective the current vaccines are for protection against circulating strains.
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